Sentence examples for marketing approval of from inspiring English sources
In light of the recent marketing approval of the first OV in the Western world, strategies for further upscaling OV manufacturing and optimizing product characterization will receive increasing attention.
The Food and Drug Administration turned down Wyeth's application for marketing approval of the product, known as rhBMP-2/ACS and designed for use in helping heal fractures of long bones.
Connetics said it would not seek marketing approval of relaxin after a 239-patient study found that it did not substantially ease hardening of the skin, a primary symptom of scleroderma.
The marketing approval of genetically engineered hematopoietic stem cells (HSCs) as the first-line therapy for the treatment of severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID) is a tribute to the substantial progress that has been made regarding HSC engineering in the past decade.
The IP chapter also includes commitments on the protection of undisclosed tests and other data submitted to obtain marketing approval of a new pharmaceutical or agricultural chemical product.
The key strategies required in preclinical product development to marketing approval of the products in Europe, Japan, and the U.S. will be compared and discussed.
The marketing approvals of medical products based on regenerative technologies will depend on data collected from clinical trials that are designed to evaluate the safety and efficacy of an investigational product.
The NDA contains all of the information and data that the FDA requires for market approval of a drug.
The low level of gilt yields is often cited by ministers as a sign of market approval of the government's deficit-cutting strategy.
The F.D.A. and the Environmental Protection Agency continue to investigate the contamination and could take actions including revoking the market approval of StarLink.
They are subject to selection bias even when carefully designed; thus, they are generally not acceptable as the sole basis for pre-market approval of high risk cardiovascular devices.
